Select Page

Bibliografía COVID-19 Diabetes & Endocrinología

Jun 10, 2020

02/08/20

Diabetes mellitus y Covid-19. Epidemiología, fisiopatología, manejo ambulatorio e intrahospitalario. Revisión
Patricio Salman M, Patricia C. Gómez G, Néstor Soto I.
Rev. chil. endocrinol. diabetes 2020; 13 (4)  Artículo Original (PRE PRINT)

The Impact of SARS-Cov-2 Virus Infection on the Endocrine System.
Somasundaram NP, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Dissanayake HA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Katulanda P, Grossman AB.
J Endocr Soc. 2020 Jul 2

Endocrine and metabolic aspects of the COVID-19 pandemic.
Marazuela M, Giustina A, Puig-Domingo M.Rev Endocr Metab Disord. 2020 Jul 9:1-13

Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature.
Katulanda P, Dissanayake HA, Ranathunga I, Ratnasamy V, Wijewickrama PSA, Yogendranathan N, Gamage KKK, de Silva NL, Sumanatilleke M, Somasundaram NP, Matthews DR.Diabetologia. 2020 Aug;63(8):1440-1452

Diabetes Epidemiology in the COVID-19 Pandemic
Elizabeth Selvin, Stephen P. Juraschek
Diabetes Care Aug 2020, 43 (8) 1690-1694

COVID-19 impact on people with diabetes in South and Central America(SACA region).
Barone MTU, Villarroel D, de Luca PV, Harnik SB, Lima BLS, Wieselberg RJP, Giampaoli V.Diabetes Res Clin Pract. 2020 Jul 3

Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y, Xu J, Wu F, Duan L, Yin Z, Luo H, Xiong N, Xu M, Zeng T, Jin Y.
Diabetologia. 2020 Jul 10:1-10

Effects of COVID-19 Lockdown on Glucose Control: Continuous Glucose Monitoring Data From People With Diabetes on Intensive Insulin Therapy
Ernesto Maddaloni, Lucia Coraggio, Silvia Pieralice, Angela Carlone, Paolo Pozzilli, RaffaellaBuzzetti
Diabetes Care Aug 2020, 43 (8) e86-e8

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, Oliver Schnell, Jan Škrha, Paul Valensi
Diabetes Care Jul 2020, 43 (7) 1427-143

Caring for Older Adults With Diabetes During the COVID-19 Pandemic.
Sy SL, Munshi MN.JAMA Intern Med. 2020 Jul 13

COVID-19 and type 1 diabetes: Challenges and actions.
Klatman EL, Besançon S, Bahendeka S, Mayige M, Ogle GD.Diabetes Res Clin Pract. 2020 Jun 24;166:108275

Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J.Diabetes Res Clin Pract. 2020 Jun 25;166:108279. doi: 10.1016

How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.
Rottoli M, Bernante P, Belvedere A, Balsamo F, Garelli S, Giannella M, Cascavilla A, Tedeschi S, Ianniruberto S, Rosselli Del Turco E, Tonetti T, Ranieri VM, Poggioli G, Manzoli L, Pagotto U, Viale P, Bartoletti M.Eur J Endocrinol. 2020 Jul 1:EJE-20-0541.R2

Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report.
RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ.N Engl J Med. 2020 Jul 17

Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity.
Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, Boot CS, Stock N, Macfarlane J, Martineau AR, Burns G, Quinton R.Clin Endocrinol (Oxf). 2020 Jul 3

Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.
Chen M, Zhou W, Xu W.Thyroid. 2020 Jul 10

Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic.
Almeida MQ, Mendonca BB.Clinics (Sao Paulo). 2020 Jun 12;7

Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective.
Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, McCormack A, Pineyro MM, Syro LV, Tritos NA, Marcus HJ.Pituitary. 2020 Aug;23(4):327-337

COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess.
Pivonello R, Ferrigno R, Isidori AM, Biller BMK, Grossman AB, Colao A.Lancet Diabetes Endocrinol. 2020 Aug;8(8):654-656

10/07/20

Collaborative Open-Access Virtually Individualized Decision-Algorithms for Inpatient Diabetes

Sitio American Diabetes Association con artículos actualizados Diabetes Care
https://care.diabetesjournals.org/collection/diabetes-and-COVID19

Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
Drucker DJ.Endocr Rev. 2020 Jun 1;41(3):bnaa011. doi: 10.1210/endrev/bnaa011

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study.
Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, Amadou C, Arnault G, Baudoux F, Bauduceau B, Borot S, Bourgeon-Ghittori M, Bourron O, Boutoille D, Cazenave-Roblot F, Chaumeil C, Cosson E, Coudol S, Darmon P, Disse E, Ducet-Boiffard A, Gaborit B, Joubert M, Kerlan V, Laviolle B, Marchand L, Meyer L, Potier L, Prevost G, Riveline JP, Robert R, Saulnier PJ, Sultan A, Thébaut JF, Thivolet C, Tramunt B, Vatier C, Roussel R, Gautier JF, Gourdy P; CORONADO investigators.Diabetologia. 2020 May 29:1-16. doi: 10.1007/s00125-020-05180-x

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.
Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, Fermín-Martínez CA, Naveja JJ, Aguilar-Salinas CA.J Clin Endocrinol Metab. 2020 May 31:dgaa346. doi: 10.1210/clinem/dgaa346

A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19Pandemic.
Korytkowski M, Antinori-Lent K, Drincic A, Hirsch IB, McDonnell ME, Rushakoff R, Muniyappa R.J Clin Endocrinol Metab. 2020 Jun 4:dgaa342. doi: 10.1210/clinem/dgaa342

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
Ceriello A, Schnell O.J Diabetes Sci Technol. 2020 May 30:1932296820930025. doi: 10.1177/1932296820930025

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Zhu L, et al. Cell Metab. 2020. PMID: 32369736

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
Antonio Ceriello, Eberhard Standl, Doina Catrinoiu, Baruch Itzhak, Nebojsa M. Lalic, Dario Rahelic, Oliver Schnell, Jan Škrha, Paul Valensi, on behalf of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
Diabetes Care 2020 May; dc200941.

The Diagnosis and Management of Gestational Diabetes Mellitus in the Context of the COVID-19 Pandemic.
McIntyre HD, Moses RG.Diabetes Care. 2020 May 14:dci200026. doi: 10.2337/dci20-0026

Endocrinology in the time of COVID-19
https://eje.bioscientifica.com/page/covid19-collection

COVID-19 and the endocrine system: exploring the unexplored.
Pal R, Banerjee M.J Endocrinol Invest. 2020 May 2:1-5. doi: 10.1007/s40618-020-01276-8.

Endocrine Conditions and COVID-19.
Shekhar S, Wurth R, Kamilaris CDC, Eisenhofer G, Barrera FJ, Hajdenberg M, Tonleu J, Hall JE, Schiffrin EL, Porter F, Stratakis CA, Hannah-Shmouni F.Horm Metab Res. 2020 Jun 8. doi: 10.1055/a-1172-1352.

Commentary: Myths and facts on vitamin D amidst the COVID-19 pandemic.
Chakhtoura M, Napoli N, El Hajj Fuleihan G.Metabolism. 2020 May 26;109:154276. doi: 10.1016/j.metabol.2020.154276

Vitamin D concentrations and COVID-19 infection in UK Biobank.
Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz CL, Jani BD, Welsh P, Mair FS, Gray SR, O’Donnell CA, Gill JM, Sattar N, Pell JP.Diabetes Metab Syndr. 2020 May 7;14(4):561-565. doi: 10.1016/j.dsx.2020.04.050

Joint Guidance on Osteoporosis Management in the Era of COVID-19
from the American Society for Bone and Mineral Research (ASBMR), American Association of Clinical Endocrinologists (AACE), Endocrine Society, European Calcified Tissue Society (ECTS) and National Osteoporosis Foundation (NOF) 

Osteoporosis Management in the Era of COVID-19.
Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT.J Bone Miner Res. 2020 May 14:10.1002/jbmr.4049. doi: 10.1002/jbmr.4049

Thyroid disease in the time of COVID-19.
Dworakowska D, Grossman AB.Endocrine. 2020 Jun 7:1-4. doi: 10.1007/s12020-020-02364-8

BTA/SFE statement regarding issues specific to thyroid dysfunction during the COVID -19 pandemic
https://www.british-thyroid-association.org/sandbox/bta2016/management-of-thyroid-dysfunction-during-covid-19_final.pdf

Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19pandemic.
Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML.J Endocrinol Invest. 2020 May 21:1-3. doi: 10.1007/s40618-020-01293-7

Subacute Thyroiditis After Sars-COV-2 Infection.
Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F.J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa276. doi: 10.1210/clinem/dgaa276

Handling of Thyroid FNA Samples During the COVID-19 Pandemic
Liron Pantanowitz
Published Online:6 May 2020

Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
Berton AM, Prencipe N, Giordano R, Ghigo E, Grottoli S.J Endocrinol Invest. 2020 Jun 8. doi: 10.1007/s40618-020-01325-2

Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?
Lombardi CP, D’Amore A, Grani G, Ramundo V, Boscherini M, Gordini L, Marzi F, Tedesco S, Bocale R.Endocrine. 2020 Jun 4:1-4. doi: 10.1007/s12020-020-02357-7

Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown.
Navarra G, Komaei I, Currò G, Angrisani L, Bellini R, Cerbone MR, Di Lorenzo N, De Luca M, Foletto M, Gentileschi P, Musella M, Nannipieri M, Piazza L, Olmi S, Pilone V, Raffaelli M, Sarro G, Vitiello A, Zappa MA, Foschi D.Updates Surg. 2020 Jun 8. doi: 10.1007/s13304-020-00821-7

COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.
Puig-Domingo M, Marazuela M, Giustina A.
Endocrine. 2020 Apr;68(1)

Our Response to COVID-19 as Endocrinologists and Diabetologists.
Kaiser UB, Mirmira RG, Stewart PM.
J Clin Endocrinol Metab. 2020 May 1;105(5)

Commentary: COVID-19 in patients with diabetes.
Hill MA, Mantzoros C, Sowers JR.
Metabolism. 2020 Mar 24;107:154217

Prevalence and impact of diabetes among people infected with SARS-CoV-2.
Fadini GP, Morieri ML, Longato E, Avogaro A.
J Endocrinol Invest. 2020 Mar 2

COVID-19 in patients with diabetes: risk factors that increase morbidity.
Klonoff DC, Umpierrez GE.
Metabolism2020 Apr 7:154224

Practical recommendations for the management of diabetes in patients with COVID-19.
Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B.
Lancet Diabetes Endocrinol. 2020 Apr 23

Diabetes and COVID-19.
Bloomgarden ZT
J Diabetes. 2020 Apr;12(4):347-348. doi: 10.1111/1753-0407.13027.

Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection.
Isidori AM, Pofi R, Hasenmajer V, Lenzi A, Pivonello R.
Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30149-2

Clinical management guidance during the COVID-19 Pandemic: Adrenal Insufficiency
Wiebke Arlt1, Stephanie E. Baldeweg, Simon H. S. Pearce, Helen L. Simpson

Endocrinology in the time of COVID-19: Management of Diabetes insipidus and Hyponatraemia
Mirjam Christ-Crain, Ewout J. Hoorn, Mark Sherlock, Chris J Thompson, John A H Wass

BAETS statement on COVID-19 and Thyroid Cancer Services

Osteoporosis in the age of COVID-19.
Girgis CM, Clifton-Bligh RJ.
Osteoporos Int. 2020 Apr 28

COVID-19 and Osteoporosis. Recommendations from International Osteoporosis Foundation

Diabetes and COVID-19
Zachary T. Bloomgarden
Department of Medicine, Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York

Journal Pre-proof
COVID-19 in patients with diabetes: risk factors that increase morbidity
David C. Klonoff, Guillermo E. Umpierrez
PII: S0026-0495(20)30088-3